Comerica Securities’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,872
| Closed | -$895K | – | 504 |
|
|
2021
Q2 | $895K | Sell |
4,872
-2,814
| -37% | -$517K | 0.07% | 234 |
|
|
2021
Q1 | $1.18M | Sell |
7,686
-6,107
| -44% | -$934K | 0.09% | 192 |
|
|
2020
Q4 | $2.16M | Buy |
13,793
+1,702
| +14% | +$266K | 0.17% | 118 |
|
|
2020
Q3 | $1.38M | Sell |
12,091
-1,974
| -14% | -$226K | 0.12% | 147 |
|
|
2020
Q2 | $1.58M | Buy |
14,065
+1,080
| +8% | +$121K | 0.15% | 134 |
|
|
2020
Q1 | $1.17M | Buy |
12,985
+719
| +6% | +$64.6K | 0.13% | 149 |
|
|
2019
Q4 | $1.33M | Buy |
12,266
+290
| +2% | +$31.4K | 0.13% | 167 |
|
|
2019
Q3 | $1.17M | Buy |
11,976
+1,513
| +14% | +$148K | 0.12% | 168 |
|
|
2019
Q2 | $1.37M | Buy |
10,463
+3,993
| +62% | +$523K | 0.15% | 149 |
|
|
2019
Q1 | $875K | Buy |
6,470
+2,430
| +60% | +$329K | 0.1% | 204 |
|
|
2018
Q4 | $393K | Sell |
4,040
-950
| -19% | -$92.4K | 0.05% | 283 |
|
|
2018
Q3 | $694K | Buy |
4,990
+375
| +8% | +$52.2K | 0.08% | 234 |
|
|
2018
Q2 | $573K | Buy |
4,615
+355
| +8% | +$44.1K | 0.07% | 250 |
|
|
2018
Q1 | $475K | Buy |
4,260
+1,015
| +31% | +$113K | 0.06% | 275 |
|
|
2017
Q4 | $388K | Buy |
3,245
+189
| +6% | +$22.6K | 0.05% | 298 |
|
|
2017
Q3 | $429K | Buy |
3,056
+662
| +28% | +$92.9K | 0.06% | 274 |
|
|
2017
Q2 | $291K | Buy |
2,394
+196
| +9% | +$23.8K | 0.04% | 325 |
|
|
2017
Q1 | $266K | Buy |
+2,198
| New | +$266K | 0.04% | 333 |
|
|
2015
Q3 | – | Sell |
-2,396
| Closed | -$433K | – | 349 |
|
|
2015
Q2 | $433K | Buy |
+2,396
| New | +$433K | 0.11% | 208 |
|